Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|17|2041-2062

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.17, 2004-07, pp. : 2041-2062

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry of Small Molecule CCR5 Antagonists for Blocking HIV-1 Entry: A Review of Structural Evolution

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1515-1538

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors

By  

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 100-112

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Small-molecule CCR5 Inhibitors for HIV

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-11 ,pp. : 1277-1292

Bentham Science Publishers

Access to resources Recommend Favorite

Virostatics: A New Class of Anti-HIV Drugs

By  

Current Medicinal Chemistry, Vol. 14, Iss. 2, 2007-01 ,pp. : 233-241

Bentham Science Publishers

Access to resources Recommend Favorite